ACAD Forecast and Technical Stock AnalysisSell candidate since 2019-07-19
ACADIA Pharmaceuticals Inc. fell by -1.72% in the last day ( Friday, 19th Jul 2019 ) from $26.15 to $25.70 During day the stock fluctuated 2.19% from a day low at $25.54 to a day high of $26.10. The price has fallen in 7 of the last 10 days and is down by -5.31% for this period. Volume has increased in the last day by 0.36 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.13 million shares bought and sold for approximately $29.11 million.
- 30 day high of the ACAD stock price was $27.75 and low was $25.02.
- 90 day high was $27.75 and low was $23.19.
- 52 week high for the ACADIA Pharmaceuticals Inc. - $28.67 and low - $12.77.
ACADIA Pharmaceuticals Inc. lies in the lower part of a wide and weak rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $25.03 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 7.47% during the next 3 months and, with 90% probability hold a price between $26.90 and $30.57 at the end of this period.
There are few to none technical positive signals at the moment. ACADIA Pharmaceuticals Inc. holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $26.41 and $26.02. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday July 18, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 39 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
Support & Resistance
ACADIA Pharmaceuticals Inc. finds support from accumulated volume at $25.57.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.56 (2.19%) between high and low. For the last week, the stock has had a daily average volatility of 3.19%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
3.19 %Average volatility
Very Low Low Medium High Very High
The ACADIA Pharmaceuticals Inc. stock holds several negative signals and despite the positive trend we believe ACADIA Pharmaceuticals Inc. will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Sell Candidate.
|ACAD $25.70 ($-0.45 -1.72%)|
ACAD is down $0.45 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACAD based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ACAD analysis is free »
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now